MiNK Therapeutics Inc. (NASDAQ: INKT) Stock Information | RedChip

MiNK Therapeutics Inc. (NASDAQ: INKT) Listen to this Section


$0.81
-0.0160 ( -1.95% ) 40.8K

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Market Data


Open


$0.81

Previous close


$0.82

Volume


40.8K

Market cap


$31.88M

Day range


$0.81 - $0.84

52 week range


$0.75 - $1.90

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024
4 Insider transactions 1 Dec 05, 2023
4 Insider transactions 1 Dec 05, 2023
4 Insider transactions 1 Dec 05, 2023
4 Insider transactions 1 Dec 05, 2023
10-q Quarterly Reports 46 Nov 14, 2023
8-k 8K-related 14 Nov 09, 2023
8-k 8K-related 12 Oct 17, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.